SNN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.163000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.169000E-01
Normal-vs-Stage2
3.165800E-01
Normal-vs-Stage3
2.919800E-01
Normal-vs-Stage4
1.873220E-01
Stage1-vs-Stage2
9.539400E-01
Stage1-vs-Stage3
6.769200E-01
Stage1-vs-Stage4
9.998600E-01
Stage2-vs-Stage3
6.938400E-01
Stage2-vs-Stage4
9.622000E-01
Stage3-vs-Stage4
7.293400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.160800E-01
Normal-vs-AfricanAmerican
3.593000E-01
Normal-vs-Asian
2.665400E-01
Caucasian-vs-AfricanAmerican
5.472800E-01
Caucasian-vs-Asian
2.041000E-01
AfricanAmerican-vs-Asian
7.557700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.007800E-01
Normal-vs-Female
3.388600E-01
Male-vs-Female
9.025500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.170600E-01
Normal-vs-Age(41-60Yrs)
3.562600E-01
Normal-vs-Age(61-80Yrs)
3.001800E-01
Normal-vs-Age(81-100Yrs)
3.075600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.648600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.555800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.865600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.734500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.050600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.834200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.206000E-01
Normal-vs-Daily Drinker
2.882400E-01
Normal-vs-Weekly Drinker
2.873200E-01
Normal-vs-Occasional Drinker
3.251000E-01
Normal-vs-Social Drinker
3.656400E-01
Non Drinker-vs-Daily Drinker
4.325400E-01
Non Drinker-vs-Weekly Drinker
4.317000E-01
Non Drinker-vs-Occasional Drinker
9.587000E-01
Non Drinker-vs-Social Drinker
4.890400E-01
Daily Drinker-vs-Weekly Drinker
9.649000E-01
Daily Drinker-vs-Occasional Drinker
4.710800E-01
Daily Drinker-vs-Social Drinker
1.397610E-01
Weekly Drinker-vs-Occasional Drinker
4.663400E-01
Weekly Drinker-vs-Social Drinker
1.432410E-01
Occasional Drinker-vs-Social Drinker
5.475600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.271800E-01
Normal-vs-Grade 2
1.140360E-01
Normal-vs-Grade 3
2.145400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.954200E-01
Grade 1-vs-Grade 3
6.864400E-01
Grade 1-vs-Grade 4
3.271800E-01
Grade 2-vs-Grade 3
5.517400E-01
Grade 2-vs-Grade 4
1.140360E-01
Grade 3-vs-Grade 4
2.145400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.008000E-01
Normal-vs-NonDiabetic
3.120200E-01
Diabetic-vs-NonDiabetic
6.507400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.364600E-01
Normal-vs-NoPancreatitis
3.104800E-01
Pancreatitis-vs-NoPancreatitis
6.497200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.267800E-01
Normal-vs-N1
3.148200E-01
N0-vs-N1
6.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.642400E-01
Normal-vs-TP53-NonMutant
2.760400E-01
TP53-Mutant-vs-TP53-NonMutant
6.739800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
